Associate Medical Director, Renal Cancer Theranostics

Telix Pharmaceuticals (AMER)

20h

About The Position

The Associate Medical Director, Renal Cancer Theranostics leads execution of the US medical affairs plan across Telix’s renal cancer theranostic portfolio. In partnership with the VP of Medical Affairs Americas, the role contributes to medical strategy, launch readiness, lifecycle planning, and the medical operating plan. It coordinates medical deliverables with Commercial, Clinical Operations, Marketing, Market Access, HEOR, Regulatory, Development, and other Medical Affairs partners. The role develops and delivers medical-plan components such as medical education, advisory boards, podium and speaker content, investigator-initiated trial strategy, clinical trial recruitment support, and scientific communications. As a subject-matter expert in renal cancer radiopharmaceuticals and the renal cancer patient journey, the Associate Medical Director stays current on publications, trials, guidelines, standards of care, and competitive data, translating emerging evidence into recommendations for medical leadership. The position also supports clinical protocol review, investigator engagement, evidence planning, scientific relationships, and compliant medical content development.

Requirements

Advanced degree (PhD, PharmD, or MD) with renal oncology experience, or equivalent experience.
At least 8 years of Medical Affairs experience, including experience leading cross-functional initiatives in oncology or specialty therapeutics.
Experience working with clinical operations, R&D, and/or medical affairs.
Experience interpreting scientific data, market research, competitive intelligence, clinical utility evidence, and evolving clinical practice dynamics.
Proficiency in Microsoft Office Suite.
Demonstrated ability to contribute to medical strategy and lead cross-functional execution in a matrixed environment.
Ability to interact internally and externally to support overall company business strategy.
Knowledge of clinical trial methodology and regulatory requirements governing clinical trials, and experience in development strategy and protocol design.
Ability to collaborate effectively across matrixed teams and influence without direct reporting authority.
Excellent verbal, written, and presentation communication skills, including developing medical content for scientific exchange, preparing speakers, and delivering podium presentations.
Demonstrated ability to develop and execute medical affairs tactical plans incorporating lifecycle planning, competitive positioning, clinical utility, IITs, and clinical trial recruitment support.
Commitment to staying current on relevant publications, clinical trials, congress data, and guideline updates for renal cancer radiopharmaceuticals and theranostics.
Detailed knowledge of regulations and compliance practices related to industry interactions with healthcare professionals.
Experience building relationships with KOLs, investigators, and professional societies in oncology.
Proven track record of delivering results that meet or exceed targeted objectives.
Valid driver’s license.

Nice To Haves

Deep expertise in renal cancer radiopharmaceuticals, theranostics, imaging and therapy integration, and the renal cancer patient journey.

Responsibilities

Lead execution of the US medical affairs plan for the renal cancer theranostic portfolio and contribute to medical strategy, priorities, and the medical operating plan with the VP of Medical Affairs Americas.
Drive cross-functional alignment on medical deliverables and timelines with US Medical Affairs, Clinical Development, Commercial, Market Access, HEOR, Regulatory, Marketing, and Medical Information.
Contribute to medical affairs strategy, launch readiness, and lifecycle planning, and lead integration of medical tactics and deliverables.
Provide subject-matter expertise on renal cancer theranostics, including scientific input into integrated medical planning, evidence gaps, and the competitive landscape.
Provide medical leadership on renal cancer clinical protocol review, recruitment strategy, data interpretation, investigator engagement, expanded access programs, clinical registries, and IIT protocol review.
Develop and review scientifically accurate medical content, including podium presentation materials, speaker decks, medical education programs, advisory board content, symposia materials, and promotional and non-promotional resources through MLR review.
Prepare and support internal and external speakers, ensuring scientific narratives, clinical context, competitive landscape, and data use are clear, balanced, compliant, and aligned with medical strategy.
Build and maintain scientific relationships with KOLs, investigators, and professional societies in renal cancer theranostics.
Maintain current knowledge of renal cancer radiopharmaceutical publications, clinical trials, treatment guidelines, patient journey dynamics, and competitive data, and translate implications into recommendations for medical leadership.